OWL Biomedical Raises $3.0M

Santa Barbara-based OWL Biomedical, a developer of microchip-based disposable cell sorting technology for the biomedical industry, has raised $3.0M, part of an ongoing funding with a target of $16.8M, according to regulatory filings. OWL is a biotech firm which is a spinout of MEMS foundry Innovative Micro Technology. Dr. John Foster, the CEO of IMT, recently left IMT to join OWL Biomedical. According to the Pacific Coast Business Times, OWL has so far raised a total of $6M in funding for the company. Name of the investors in the firm have not been announced. More information »